H
Herlev Hospital | Nephrology Department
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Polatuzumab
Runimotamab
vitamin K
LY2835219
Abemaciclib
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 5 total trials
This is a phase III, randomized, open-label, multicenter trial, conducted in Sweden, Norway, Finland, Denmark, Italy, Australia and New Zealand, in e...
Enrolling
DLBCL
Diffuse Large B Cell Lymphoma
Drug: R-pola-mini-CHP
Drug: R-mini-CHOP
This study will evaluate the safety, tolerability, and pharmacokinetics of Runimotamab administered intravenously as a single agent and in combinatio...
Active, not recruiting
Solid Tumors
Drug: Trastuzumab
Drug: Runimotamab
The purpose of this study is to evaluate the safety and efficacy of the study drug abemaciclib in participants with high risk, node positive, early s...
Active, not recruiting
Breast Cancer
Drug: Standard Adjuvant Endocrine Therapy
Drug: Abemaciclib
Trial sponsors
H
N
N
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems